Patient-reported Outcomes in Gastroenterology: Clinical and Research Applications

Overview

Journal J Neurogastroenterol Motil

Date 2013 May 14

PMID 23667745

Citations 31

Authors

Brennan M R Spiegel

Affiliations

Soon will be listed here.

Abstract

Patient-generated reports, also known as Patient-Reported Outcomes (PROs), capture the patients' illness experience in a structured format and may help bridge the gap between patients and providers. PROs measure any aspect of patient-reported health (e.g., physical, emotional or social symptoms) and can help to direct care and improve clinical outcomes. When clinicians systematically collect patient-reported data in the right place at the right time, PRO measurement can effectively aid in detection and management of conditions, improve satisfaction with care and enhance the patient-provider relationship. This review article summarizes the latest approaches to PRO measuring for clinical trials and clinical practice, with a focus on use of PROs in gastroenterology.

Citing Articles

Beyond gluten-free diet: a critical perspective on phase 2 trials on non-dietary pharmacological therapies for coeliac disease.

Scalvini D, Scarcella C, Mantica G, Bartolotta E, Maimaris S, Fazzino E Front Nutr. 2025; 11():1501817.

PMID: 39839296 PMC: 11748180. DOI: 10.3389/fnut.2024.1501817.

Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in Remission.

Cross R, Sauk J, Zhuo J, Harrison R, Kerti S, Emeanuru K Gastro Hep Adv. 2024; 1(6):927-935.

PMID: 39131245 PMC: 11307635. DOI: 10.1016/j.gastha.2022.07.003.

Composite quality measures of abdominal surgery at a population level: systematic review.

Rajesh J, Sorensen J, McNamara D BJS Open. 2023; 7(6).

PMID: 37931232 PMC: 10627522. DOI: 10.1093/bjsopen/zrad082.

Patient Preferences for the Management of Gastrointestinal Symptoms in Kidney Transplantation: a Discrete Choice Experiment.

Cooper T, Dalton A, Kieu A, Gately R, Bourke M, Craig J Kidney Int Rep. 2023; 8(10):1978-1988.

PMID: 37850002 PMC: 10577360. DOI: 10.1016/j.ekir.2023.07.034.

Supportive care interventions for managing gastrointestinal symptoms following treatment for colorectal cancer: a systematic review.

Ju A, Wiltink L, Walker J, White K, Rutherford C J Cancer Surviv. 2023; 18(5):1640-1647.

PMID: 37280309 PMC: 11424733. DOI: 10.1007/s11764-023-01403-3.

References

Schmulson M, Ortiz O, Mejia-Arangure J, Hu Y, Morris C, Arcila D . Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina. Dig Dis Sci. 2007; 52(11):2950-5. DOI: 10.1007/s10620-006-9689-9. View

Radajewski R, Hazebroek E, Berry H, Leibman S, Smith G . Short-term symptom and quality-of-life comparison between laparoscopic Nissen and Toupet fundoplications. Dis Esophagus. 2008; 22(1):84-8. DOI: 10.1111/j.1442-2050.2008.00887.x. View

Bakx R, Sprangers M, Oort F, van Tets W, Bemelman W, Slors J . Development and validation of a colorectal functional outcome questionnaire. Int J Colorectal Dis. 2004; 20(2):126-36. DOI: 10.1007/s00384-004-0638-9. View

Satoh S, Sato K, Habuchi T, Matsuo S, Sasaki S, Kato T . Health-related quality of life of ileocecal rectal bladder compared with ileal conduit diversion: a questionnaire survey. Int J Urol. 2002; 9(7):385-91; discussion 391. DOI: 10.1046/j.1442-2042.2002.00486_1.x. View

Mouzas I, Fragkiadakis N, Moschandreas J, Karachristos A, Skordilis P, Kouroumalis E . Validation and results of a questionnaire for functional bowel disease in out-patients. BMC Public Health. 2002; 2:8. PMC: 116426. DOI: 10.1186/1471-2458-2-8. View

Araujo Teixeira J, Mosquera V, Flores A . Long-term outcomes of quality of life after laparoscopic Nissen fundoplication. Hepatogastroenterology. 2009; 56(89):80-4. View

de Cassia Domansky R, Santos V . Cross-cultural adaptation and validation of the Portuguese version of the Bowel Function in the Community instrument. J Wound Ostomy Continence Nurs. 2007; 34(6):671-7. DOI: 10.1097/01.WON.0000300280.82262.61. View

Dupuis L, Taddio A, Kerr E, Kelly A, MacKeigan L . Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy. 2006; 26(9):1221-31. DOI: 10.1592/phco.26.9.1221. View

Khanna D, Hays R, Park G, Braun-Moscovici Y, Mayes M, McNearney T . Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum. 2007; 57(7):1280-6. DOI: 10.1002/art.22987. View

10.

Jones R, Coyne K, Wiklund I . The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther. 2007; 25(12):1451-9. DOI: 10.1111/j.1365-2036.2007.03343.x. View

11.

Temple L, Bacik J, Savatta S, Gottesman L, Paty P, Weiser M . The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer. Dis Colon Rectum. 2005; 48(7):1353-65. DOI: 10.1007/s10350-004-0942-z. View

12.

Bharucha A, Locke 3rd G, Seide B, Zinsmeister A . A new questionnaire for constipation and faecal incontinence. Aliment Pharmacol Ther. 2004; 20(3):355-64. DOI: 10.1111/j.1365-2036.2004.02028.x. View

13.

Hiller L, Radley S, Mann C, Radley S, Begum G, Pretlove S . Development and validation of a questionnaire for the assessment of bowel and lower urinary tract symptoms in women. BJOG. 2002; 109(4):413-23. DOI: 10.1111/j.1471-0528.2002.01147.x. View

14.

van der Veek P, van Rood Y, Masclee A . Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008; 6(3):321-8. DOI: 10.1016/j.cgh.2007.12.005. View

15.

Cook K, OMalley K, Roddey T . Dynamic assessment of health outcomes: time to let the CAT out of the bag?. Health Serv Res. 2005; 40(5 Pt 2):1694-711. PMC: 1361218. DOI: 10.1111/j.1475-6773.2005.00446.x. View

16.

Malaty H, OMalley K, Abudayyeh S, Graham D, Gilger M . Multidimensional measure for gastroesophageal reflux disease (MM-GERD) symptoms in children: a population-based study. Acta Paediatr. 2008; 97(9):1292-7. DOI: 10.1111/j.1651-2227.2008.00866.x. View

17.

Coyne K, Wiklund I, SCHMIER J, Halling K, Degl Innocenti A, Revicki D . Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003; 18(9):907-15. DOI: 10.1046/j.1365-2036.2003.01674.x. View

18.

Knowles C, Eccersley A, Scott S, Walker S, REEVES B, Lunniss P . Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS). Dis Colon Rectum. 2000; 43(10):1419-26. DOI: 10.1007/BF02236639. View

19.

Bijkerk C, de Wit N, Muris J, Jones R, Knottnerus J, Hoes A . Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol. 2003; 98(1):122-7. DOI: 10.1111/j.1572-0241.2003.07158.x. View

20.

FRANK L, Kleinman L, Farup C, Taylor L, Miner Jr P . Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999; 34(9):870-7. DOI: 10.1080/003655299750025327. View